Skip to content
Back to Investors
Ascension

Ascension

Venture Capital

Ascension Ventures is a venture capital firm that led the pre-seed funding round for Voxmind.


Recent investments

Pre-Seed
$1.1M

Concept Ventures led the pre-seed investment round to help scale the London-based team and accelerate product features.

"Mainstream generative image platforms can be really impressive, but they simply aren’t fit for purpose when it comes to a sector like architecture and design. In our industry, detail and precision is everything. Gendo has been designed specifically for these professionals; we’ve built an AI platform that speeds up design work and allows creativity to flourish."
— George Proud, Co-founder and CEO
Seed
£2.0M

Ascension led the oversubscribed seed round with backing from a syndicate of co-investors.

"Our ability to help homeowners access affordable energy via our Flexx platform and virtual power plant drives energy security and helps the UK get to a clean, green future. When we launched Heatio two years ago, our priority was to help more consumers access green technology and reduce the use of fossil fuels to decarbonise their homes. Through this investment, we are moving closer to making that a reality. We are looking forward to driving our expansion and working with industry leaders and would like to extend our appreciation to every investor for helping us get where we are today."
— Simon Roberts, CEO
Series B
£29.0M

The funding round was led by Round2 Capital and will support international expansion and software scaling.

"We’ve been on a mission to solve schools’ workforce challenges. This investment brings us closer to our goal of helping the education system save over $125 million annually through our fairer, more efficient recruitment model. As we enter into the next phase of our journey, we aim to reach out to more educational institutions across the UK and US."
— Slava Kremerman, CEO
Other
£4.7M

The financing round was led by SCVC with participation from a group of institutional investors and agencies.

"Essentially, our technology generates very small droplets which are ideal for peripheral inhalation drug delivery, and also the potential for systemic drug delivery through the inhalation route rather than via injection."
— Elijah Nazarzadeh
Seed
£1.1M

Aviva Ventures led the seed financing round for the London-based healthtech firm, with participation from Ascension, Oxford Capital, and Cur8 Capital.

"So far, we’ve been driven by a singular mission to unlock and simplify access to everything you need to live a healthier life, which requires a shift in how health and well-being services are provided and paid for, and means putting the user in the driver seat and giving them more control. By creating an integrated network of health providers and payers, we can improve access to personalised health services, particularly in traditionally underfunded and underserved areas, such as early diagnosis, women’s health, mental health and neurodiversity."
— David Joerring, Co-Founder and CEO